Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
Catherine E. Winbanks(Baker Heart and Diabetes Institute), Paul Gregorevic(The University of Melbourne), Mark A. Febbraio(Molecular Research Institute), Hongwei Qian(Baker Heart and Diabetes Institute), Justin L. Chen(Baker Heart and Diabetes Institute), Patricio V. Sepulveda(Baker Heart and Diabetes Institute), Kate L. Weeks(The University of Melbourne), Julie R. McMullen(Baker Heart and Diabetes Institute), Jeffrey S. Chamberlain(University of Washington), Graeme I. Lancaster(RMIT University), Craig A. Harrison(Discovery Institute), Rachel E. Thomson(Baker Heart and Diabetes Institute), James M. Allen(Muscular Dystrophy Association), Claudia Beyer(Baker Heart and Diabetes Institute)
Cited by 216
Related Papers
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
|Nature Cell Biology|2007|979
Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase
|Diabetes|2006|893
Interleukin-6 Stimulates Lipolysis and Fat Oxidation in Humans
|The Journal of Clinical Endocrinology & Metabolism|2003|758